INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
PATIENT REVENUES, net	$ 135,370	$ 141,082	$ 269,723	$ 282,367
EXPENSES:
Operating	108,641	111,440	216,754	223,718
Lease and rent expense	15,802	13,725	31,606	27,438
Professional liability	2,957	3,182	6,378	5,957
Litigation contingency expense (Note 7)	3,100	0	3,100	0
General and administrative	7,594	9,295	15,107	17,434
Depreciation and amortization	3,002	2,847	5,496	5,728
Total expenses	141,096	140,489	278,441	280,275
OPERATING INCOME (LOSS)	(5,726)	593	(8,718)	2,092
OTHER INCOME (EXPENSE):
Gain on sale of investment in unconsolidated affiliate	0	308	0	308
Other income	45	28	205	79
Interest expense, net	(1,556)	(1,661)	(3,016)	(3,330)
Total other expense	(1,511)	(1,325)	(2,811)	(2,943)
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(7,237)	(732)	(11,529)	(851)
BENEFIT (PROVISION) FOR INCOME TAXES	(17,351)	425	(16,396)	463
LOSS FROM CONTINUING OPERATIONS	(24,588)	(307)	(27,925)	(388)
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax benefit of $0 and $0, respectively	(8)	(4)	(17)	(26)
NET LOSS	$ (24,596)	$ (311)	$ (27,942)	$ (414)
Per common share – basic
Continuing operations (in dollars per share)	$ (3.80)	$ (0.05)	$ (4.33)	$ (0.06)
Discontinued operations (in dollars per share)	0.00	0.00	0.00	0.00
Net loss per common share – basic (dollars per share)	(3.80)	(0.05)	(4.33)	(0.06)
Per common share – diluted
Continuing operations (in dollars per share)	(3.80)	(0.05)	(4.33)	(0.06)
Discontinued operations (in dollars per share)	0.00	0.00	0.00	0.00
Net income (loss) per common share – diluted (dollars per share)	(3.80)	(0.05)	(4.33)	(0.06)
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK (dollars per share)	$ 0	$ 0.055	$ 0	$ 0.11
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	6,472	6,370	6,448	6,342
Diluted (shares)	6,472	6,370	6,448	6,342